Immunoblot assays revealed that BC cell–derived EVs enhanced VEGFA-induced VEGFR2 phosphorylation/activation, and the effect was augmented when the EVs were derived from hypoxic BC cells (Figure 9A). The gene discussed is VEGFA; the disease is breast cancer.